Literature DB >> 28911080

Rituximab for nivolumab plus ipilimumab-induced encephalitis in a small-cell lung cancer patient.

M Ito1, S Fujiwara2, D Fujimoto1, R Mori1, H Yoshimura2, A Hata3, N Kohara2, K Tomii1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28911080     DOI： 10.1093/annonc/mdx252

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  11 in total

Review 1.  Adverse events induced by immune checkpoint inhibitors.

Authors:  Ana Luisa Perdigoto; Harriet Kluger; Kevan C Herold
Journal:  Curr Opin Immunol       Date:  2021-02-25       Impact factor: 7.486

Review 2.  A Review of Cancer Immunotherapy Toxicity: Immune Checkpoint Inhibitors.

Authors:  Neeraj Chhabra; Joseph Kennedy
Journal:  J Med Toxicol       Date:  2021-04-07

3.  Natalizumab may control immune checkpoint inhibitor-induced limbic encephalitis.

Authors:  Andreas F Hottinger; Rita de Micheli; Vanessa Guido; Alexandra Karampera; Patric Hagmann; Renaud Du Pasquier
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-01-11

4.  Immune-Checkpoint-Inhibitor-Induced Severe Autoimmune Encephalitis Treated by Steroid and Intravenous Immunoglobulin.

Authors:  Ahwon Kim; Bhumsuk Keam; Hyeon Cheun; Soon Tae Lee; Hyung Seok Gook; Moon Ku Han
Journal:  J Clin Neurol       Date:  2019-03-11       Impact factor: 3.077

5.  Elevated Adenosine Deaminase Levels in the Cerebrospinal Fluid in Immune Checkpoint Inhibitor-induced Autoimmune Encephalitis.

Authors:  Satoru Fujiwara; Naoya Mimura; Hajime Yoshimura; Daichi Fujimoto; Munehiro Ito; Ryobu Mori; Jiro Ito; Keisuke Tomii; Michi Kawamoto; Nobuo Kohara
Journal:  Intern Med       Date:  2019-06-27       Impact factor: 1.271

6.  Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative review.

Authors:  Laure Thouvenin; Timothée Olivier; Giuseppe Banna; Alfredo Addeo; Alex Friedlaender
Journal:  Ther Adv Drug Saf       Date:  2021-03-29

Review 7.  Potential therapies for immune-related adverse events associated with immune checkpoint inhibition: from monoclonal antibodies to kinase inhibition.

Authors:  Sonia Victoria Del Rincón; Wilson H Miller; Meagan-Helen Henderson Berg
Journal:  J Immunother Cancer       Date:  2022-01       Impact factor: 13.751

Review 8.  Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events.

Authors:  Remo Poto; Teresa Troiani; Gjada Criscuolo; Giancarlo Marone; Fortunato Ciardiello; Carlo Gabriele Tocchetti; Gilda Varricchi
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

Review 9.  [Diagnosis and Treatment Recommendation and Exploration for Critical and Refractory Adverse Effects Related to Immunocheckpoint Inhibitors].

Authors:  Hanping Wang; Peng Song; Xiaoyan Si; Xiaoxiao Guo; Yue Li; Jiaxin Zhou; Lian Duan; Li Zhang; Mengzhao Wang; Li Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2019-10-20

Review 10.  Immune Checkpoint Inhibitors and Neurotoxicity.

Authors:  Zhiyi Zhao; Chunlin Zhang; Lian Zhou; Pan Dong; Lei Shi
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.